Global Hematopoietic
Stem Cells Transplantation Market Is Expected To Reach USD 7,796.1 Mn By 2022
The latest market
report published by Credence Research, Inc. “Global Hematopoietic Stem Cells
Transplantation Market - Growth, Share, Opportunities, Competitive Analysis,
and Forecast, 2016 - 2022,” the hematopoietic stem cells transplantation market
was valued at USD 3,741.3 Mn in 2015, and is expected to reach USD 7,796.1 Mn
by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Browse the
full report Hematopoietic Stem Cells Transplantation Market - Growth, Share,
Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/hematopoietic-stem-cells-transplantation-market
Market
Insights
Over 50 years of
studies in the field of blood-forming stem cells i.e. hematopoietic stem cells
(HSC), researchers have developed significant understanding to use HSCs as a
therapy. At present, no type of stem cell, adult, embryonic or fetal has
attained such sufficient status. Hematopoietic stem cell transplantation (HSCT)
is now routinely used for treating patients with malignant and non-malignant
disorders of blood and the immune system.
Currently, researchers
have observed that through animal studies HSCs have the ability to form other
cells such as blood vessels, muscles, and bone. Further application of this
approach it may eventually be able to treat a wide array of conditions and
replace ailing tissues. However, despite the vast experience with HSCs,
researchers face major barriers in expanding their use beyond the replacement
of immune and blood cells.
Hematopoietic stem
cells are unable to proliferate and differentiate in-vitro. Researchers have
yet to evolve an accurate method to differentiate stem cells from other cells
derived from blood or bone marrow. Once such technical barriers are overcome,
the avenues for realizing the full potential of HSCT. The type of transplant a
person receives depends on several different factors, including the type and
course of the disease, availability of suitable donors, and the patient’s
overall health. There are three different sources of hematopoietic stem cells
such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The
stem cell source used for a given transplant depends upon the underlying
disease, the type of transplant (allogeneic or autologous), and size of the
patient.
Market
Competition Assessment:
The hematopoietic stem
cells transplantation market is observed as the most diversified and
competitive market comprising large number of players. The market is dominated by several players,
depending on their major competencies. The key players in this market are Kite
Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer
GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd.,
TiGenix N.V., and ScienCell Research Laboratories.
Key Market
Movements:
Rising prevalence of
leukemia is expected to assist the hematopoietic stem cells transplantation as
the survival rates in leukemia patients has been improved after HSCT.
Future opportunity for
HSCT market lies in regenerative Stromal Cell Therapy because it is considered
as one of the novel therapies for prevention and treatment of acute graft
versus host disease in allogeneic HSCT patients.
In emerging economies
growing government support through providing favorable environments for
research laboratories in the field of stem cell research
About Us:
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales
Manager)
Address:
105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290
No comments:
Post a Comment